Dental ImplantTAOM-TANCT05927181
Immediate Implants: to Graft or Not to Graft, That is the Question.
A study testing TAOM in people with Dental Implant, run by Universidad Complutense de Madrid at 1 site in Spain.
Trial summary
The aim was to compare two protocols for immediate implants with fixed provisional restoration, no grafting (trimodal approach=TA) versus grafting both osseous gap and peri-implant mucosa (trimodal approach with modification of the osseous and mucosal compartments =TAOM) by measuring the soft tissue changes overtime. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Dental Implant
- What is being tested?
- TAOM
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 31 participants
- Where
- 1 siteSpain
- Study dates
- Apr 2009to Feb 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Need for tooth extraction in the anterior maxilla (13-23) due to cavities, internal resorption, fractures, restorative problems, endodontic complications and prosthetic reasons.
- The failing tooth has adjacent and opposing natural teeth
- Adequate oral hygiene (Bleeding on probing <20%; Plaque index <20%);
- Absence of active and uncontrolled periodontal disease
- Sufficient mesial-distal and interocclusal space for implant placement and definitive restoration
- Sufficient interocclusal space to design a non-occluding provisional restoration
Who cannot join
- Systemic metabolic or osseous disease that could compromise peri-implant tissue healing.
- Acute infection in the treatment area
- Absence of one or both adjacent teeth
- Non-integrity of the buccal bone wall (dehiscence or fenestration) observed during surgery, or when tooth extraction has altered the integrity of the osseous and gingival architecture
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Flapless Immediate Implants in Type 1 Alveoli: Soft Tissue Alterations Following a Trimodal Approach With or Without Modifying Osseous and Mucosal Compartments (TAOM vs TA) in the Aesthetic Zone: A Comparative Prospective Study.
The aim was to compare two protocols for immediate implants with fixed provisional restoration, no grafting (trimodal approach=TA) versus grafting both osseous gap and peri-implant mucosa (trimodal approach with modification of the osseous and mucosal compartments =TAOM) by measuring the soft tissue changes overtime. The periodontal phenotype was registered, to investigate a relationship between its thickness and the clinical outcomes.
Read the detailed description
The study protocol was approved by the CEIm Quiron Salud Catalunya institutional research ethic committee (Approval code:2022/102_MAX:CEX). This prospective clinical study includes patients who were enrolled and treated in two private practices (GC and JGF). All eligible patients were consecutively selected for two study groups receiving immediately placed flapless implants and the provisional restoration. Patients were informed about the characteristics of the study and signed their informed consent before the study began.
Patient population
Patients in need of single implant supported restorations in the anterior maxilla (canines, lateral and central incisors) were selected for this study. The indications for tooth extractions were cavities, endodontic complications (e.g., root fracture), internal resorption and prosthetic reasons. The patients had to fulfil the following inclusion and exclusion criteria:
Inclusion criteria:
- ≥18 years of age
- Need for tooth extraction in the anterior maxilla (13-23) due to cavities, internal resorption, fractures, restorative problems, endodontic complications and prosthetic reasons.
- The failing tooth has adjacent and opposing natural teeth
- Adequate oral hygiene (Bleeding on probing <20%; Plaque index <20%);
- Absence of active and uncontrolled periodontal disease
- Sufficient mesial-distal and interocclusal space for implant placement and definitive restoration
- Sufficient interocclusal space to design a non-occluding provisional restoration
Exclusion criteria:
- Systemic metabolic or osseous disease that could compromise peri-implant tissue healing
- Acute infection in the treatment area
- Absence of one or both adjacent teeth
- Non-integrity of the buccal bone wall (dehiscence or fenestration) observed during surgery, or when tooth extraction has altered the integrity of the osseous and gingival architecture
The participants were screened by two investigators (GC \& JGF) and comprised two consecutive study groups with the following interventions:
- Flapless immediate implant placement and provisional restoration (trimodal approach: TA) (n=15).
- Flapless immediate implant placement and provisional restoration with alveolar filling and connective tissue graft (trimodal approach with osseous and mucosal compartment modification: TAOM) (n=16).
Treatment protocol and follow-up
Four visits were intended to be delivered in each participant. Following the selection of candidates, study casts were prepared for all patients as well as preoperative photographs and parallel periapical radiographs of the problematic tooth. Rigid stents were prepared with light-cured resin, covering the incisal edges of at least one adjacent tooth on each side of the target tooth. Measurements from reference points to mid-buccal soft tissue height and mesial and distal papillae were recorded at T0. The stents were > 2 mm thick so they could be modified to allow for a perfect fit over the final restoration.
All surgical procedures were performed by two experienced surgeons and investigators (GC\& JGF). Without raising a mucoperiosteal flap, a careful tooth extraction was performed, allowing for the preservation of soft and hard tissues. In 10 patients, the Benex Extractor® (Benex Root Extraction System, Hager and Meisinger GMbH, Neuss, Germany) was used to ensure atraumatic extraction. Then, a detailed examination of the buccal bone wall was carried out to verify its integrity. In the cases when the integrity of the bone wall was in question, the patient was excluded from the study and the implant was placed by means of conventional protocols.
Measurement of the total periodontal thickness (phenotype) was taken at this time by means of an analogic calliper located 5 mm apical to the buccal gingival margin, to locate the bundle bone level.
Then, the implant bed was prepared on the palatal side of the extraction socket in accordance with the manufacturer's instructions (Bone Level -BL- and Tissue Level -TL-, Straumann AG, Switzerland; Thoma et al., 2021). The implant was placed securing the ideal position at a depth of 2mm for the TL implant and 4mm for the BL implant and in a palatal position allowing for a direct screw-retained restoration (1-3 mm from the bone wall) for all implants. It was also verified that the wall of the post-extraction socket was not perforated during implant bed preparation. The implant had to show good primary stability in its ideal position, in order to avoid being excluded from the study. In the TA group, no material was used to fill the gap between the implant and the osseous wall and no soft tissue graft was attempted either. In the TAOM group, the gap between the implant and the facial bone wall was grafted with inorganic bovine bone (Geistlich Bio-Oss®; Geistlich Pharma AG, Wolhusen, Switzerland) and, in addition, a connective tissue graft (CTG) was harvested from the anterior palate region and placed submucosally on the labial bone plate by means of an envelope technique.
Following implant placement, an acrylic resin implant-supported provisional restoration was prepared, adapted and delivered for all implants. All provisional restorations were directly screw-retained and designed with no occlusal contacts, neither in maximum intercuspal position nor in excursive movements. The emergence profile was mainly flat or concave in interproximal and palatal sides, and slightly convex in the buccal aspect to support the soft tissues for the TA group. In the TAOM group, it was slightly concave to provide space for the soft-tissue graft and avoid isquemia in the marginal mucosa. Intra-oral radiographs were taken to check implant position and the fit of the restoration. Systemic antibiotics (Azitromicin-500mg/24h/3days) and anti-inflammatories (Dexketoprofen-25mg/8h/3days) were prescribed, together with a clorhexidine 0.20 % gel twice a day for one week. Patients were then recalled for a post-operative check-up and sutures were removed after 14 days.
At 3 months, final impressions were made. After abutment selection and bisque try-ins, final restorations were permanently placed at 4 months.
The tooth-supported acrylic resin measuring stent was then adapted to allow for a complete fit on the incisal edges of both neighbouring teeth, to ensure a reliable positioning and measurement reference.
The first measurement was at day 0 (Immediate implant placement and provisionalisation). Patient recall appointments for examinations and measurements took place at 3, 6 and 12 months. No activities were performed to increase compliance or adherence in the selected patients beyong compliance of a good clinical practice.
Outcome measures The primary outcome variable of this study was the vertical midfacial soft tissue change from baseline (before tooth extraction) to 12 months following implant placement.
The secondary outcome measures were mesial and distal papillae vertical changes, periodontal phenotype at implant site, and mechanical complications.
The clinical outcomes were measured as follows:
- Vertical soft tissue changes were calculated through the distance from reference measuring points on the stent to mesial (MP) and distal (DP) papillae, and gingival zenith (Z) of the implant restoration. Distances were measured by means of a precision digital calliper that can display measurements as small as tenths of a millimetre. Three dimples were marked in the stent, in approximately the vertical projection of papillae and zenith (Supplementary figure 1a). Measurements were taken before tooth extraction (baseline) T0 and at 3 (T3), 6 (T6) and 12 (T12) months following the intervention.
- Periodontal phenotype thickness was measured by means of an analogical calliper that was able to show tenths of a millimetre. It was located 5 mm apical to the buccal gingival margin immediately after tooth extraction.
- Mechanical complications were assessed and included: screw loosening, loss of retention, chipping of acrylic or porcelain complications.
- Conditions
- Dental Implant
- Being tested
- TAOM
- Keywords
- Immediate Implants, soft tissue graft, immediate implant restoration
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TAOMProcedure or surgery
Also called Trimodal approach with osseous and mucosal interventions.
In the TAOM group, the gap between the implant and the facial bone wall was grafted with inorganic bovine bone (Geistlich Bio-Oss®; Geistlich Pharma AG, Wolhusen, Switzerland) and, in addition, a connective tissue graft (CTG) was placed submucosally on the labial bone plate by means of an envelope technique.
| Study group | Role | What they receive |
|---|---|---|
| Trimodal Approach with Osseous and Mucosal compartment modification: TAOM | Experimental | Flapless immediate implant placement and provisional restoration with alveolar filling and connective tissue graft. Receives: Procedure: TAOM |
| Trimodal Approach: TA | Active comparator | Flapless immediate implant placement and provisional restoration. Receives: Procedure: TAOM |
What is being measured
The primary outcome is the main question the study is designed to answer.
Distance from measuring points on the reference stent to gingival zenith of the implant restoration in tenths of a milimetre by means of a precision digital calliper.
Vertical midfacial soft tissue change from baseline (before tooth extraction) to 12 months following implant placement.
Measured: 12 months
Secondary outcomes (2)
Distance from measuring points on the reference stent to mesial and distal papillae of the implant restoration in tenths of a milimetres by means of a precision digital calliper.
Vertical mesial and distal papillae soft tissue change from baseline (before tooth extraction) to 12 months following implant placement.
Measured: 12 months
Periodontal thickness at 5mm apical to the gingival margin in tenths of a milimetre.
Thickness at implant site at 5 mm apical to the buccal gingival margin from the external queratinized tissue to internal part of the buccal bundle bone.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jul 2023
- Study startApr 2009
- Primary completionMar 2016
- Study completionFeb 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dental ImplantStudies of the same condition, open and under way.
- More trials run by Universidad Complutense de MadridThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidad Complutense de Madrid
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Gustavo G Cabello, Principal investigator, Private Practice, Málaga, SpainJavier J Fabrega, Principal investigator, Private Practice, Madrid, Spain
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05927181
- Sponsor's protocol ID
- TMA-USE-001
- Acronym
- TAOM-TA
- Status last verified
- May 2023
- First submitted
- 19 May 2023
- Last updated
- 3 Jul 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jul 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Flapless Immediate Implants in Type 1 Alveoli: Soft Tissue Alterations Following a Trimodal Approach With or Without Modifying Osseous and Mucosal Compartments (TAOM vs TA) in the Aesthetic Zone: A Comparative Prospective Study.
- ClinicalTrials.gov ID
- NCT05927181
- Acronym / sponsor ID
- TAOM-TA / TMA-USE-001
- Conditions
- Dental Implant
- Keywords
- Immediate Implants, soft tissue graft, immediate implant restoration
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- Universidad Complutense de MadridUniversity, hospital or other
- Study start
- Apr 2009 (actual)
- Primary completion
- Mar 2016 (actual)
- Study completion
- Feb 2020 (actual)
- First posted
- 3 Jul 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim was to compare two protocols for immediate implants with fixed provisional restoration, no grafting (trimodal approach=TA) versus grafting both osseous gap and peri-implant mucosa (trimodal approach with modification of the osseous and mucosal compartments =TAOM) by measuring the soft tissue changes overtime. The periodontal phenotype was registered, to investigate a relationship between its thickness and the clinical outcomes.
Detailed description
The study protocol was approved by the CEIm Quiron Salud Catalunya institutional research ethic committee (Approval code:2022/102_MAX:CEX). This prospective clinical study includes patients who were enrolled and treated in two private practices (GC and JGF). All eligible patients were consecutively selected for two study groups receiving immediately placed flapless implants and the provisional restoration. Patients were informed about the characteristics of the study and signed their informed consent before the study began.
Patient population
Patients in need of single implant supported restorations in the anterior maxilla (canines, lateral and central incisors) were selected for this study. The indications for tooth extractions were cavities, endodontic complications (e.g., root fracture), internal resorption and prosthetic reasons. The patients had to fulfil the following inclusion and exclusion criteria:
Inclusion criteria:
- ≥18 years of age
- Need for tooth extraction in the anterior maxilla (13-23) due to cavities, internal resorption, fractures, restorative problems, endodontic complications and prosthetic reasons.
- The failing tooth has adjacent and opposing natural teeth
- Adequate oral hygiene (Bleeding on probing <20%; Plaque index <20%);
- Absence of active and uncontrolled periodontal disease
- Sufficient mesial-distal and interocclusal space for implant placement and definitive restoration
- Sufficient interocclusal space to design a non-occluding provisional restoration
Exclusion criteria:
- Systemic metabolic or osseous disease that could compromise peri-implant tissue healing
- Acute infection in the treatment area
- Absence of one or both adjacent teeth
- Non-integrity of the buccal bone wall (dehiscence or fenestration) observed during surgery, or when tooth extraction has altered the integrity of the osseous and gingival architecture
The participants were screened by two investigators (GC \& JGF) and comprised two consecutive study groups with the following interventions:
- Flapless immediate implant placement and provisional restoration (trimodal approach: TA) (n=15).
- Flapless immediate implant placement and provisional restoration with alveolar filling and connective tissue graft (trimodal approach with osseous and mucosal compartment modification: TAOM) (n=16).
Treatment protocol and follow-up
Four visits were intended to be delivered in each participant. Following the selection of candidates, study casts were prepared for all patients as well as preoperative photographs and parallel periapical radiographs of the problematic tooth. Rigid stents were prepared with light-cured resin, covering the incisal edges of at least one adjacent tooth on each side of the target tooth. Measurements from reference points to mid-buccal soft tissue height and mesial and distal papillae were recorded at T0. The stents were > 2 mm thick so they could be modified to allow for a perfect fit over the final restoration.
All surgical procedures were performed by two experienced surgeons and investigators (GC\& JGF). Without raising a mucoperiosteal flap, a careful tooth extraction was performed, allowing for the preservation of soft and hard tissues. In 10 patients, the Benex Extractor® (Benex Root Extraction System, Hager and Meisinger GMbH, Neuss, Germany) was used to ensure atraumatic extraction. Then, a detailed examination of the buccal bone wall was carried out to verify its integrity. In the cases when the integrity of the bone wall was in question, the patient was excluded from the study and the implant was placed by means of conventional protocols.
Measurement of the total periodontal thickness (phenotype) was taken at this time by means of an analogic calliper located 5 mm apical to the buccal gingival margin, to locate the bundle bone level.
Then, the implant bed was prepared on the palatal side of the extraction socket in accordance with the manufacturer's instructions (Bone Level -BL- and Tissue Level -TL-, Straumann AG, Switzerland; Thoma et al., 2021). The implant was placed securing the ideal position at a depth of 2mm for the TL implant and 4mm for the BL implant and in a palatal position allowing for a direct screw-retained restoration (1-3 mm from the bone wall) for all implants. It was also verified that the wall of the post-extraction socket was not perforated during implant bed preparation. The implant had to show good primary stability in its ideal position, in order to avoid being excluded from the study. In the TA group, no material was used to fill the gap between the implant and the osseous wall and no soft tissue graft was attempted either. In the TAOM group, the gap between the implant and the facial bone wall was grafted with inorganic bovine bone (Geistlich Bio-Oss®; Geistlich Pharma AG, Wolhusen, Switzerland) and, in addition, a connective tissue graft (CTG) was harvested from the anterior palate region and placed submucosally on the labial bone plate by means of an envelope technique.
Following implant placement, an acrylic resin implant-supported provisional restoration was prepared, adapted and delivered for all implants. All provisional restorations were directly screw-retained and designed with no occlusal contacts, neither in maximum intercuspal position nor in excursive movements. The emergence profile was mainly flat or concave in interproximal and palatal sides, and slightly convex in the buccal aspect to support the soft tissues for the TA group. In the TAOM group, it was slightly concave to provide space for the soft-tissue graft and avoid isquemia in the marginal mucosa. Intra-oral radiographs were taken to check implant position and the fit of the restoration. Systemic antibiotics (Azitromicin-500mg/24h/3days) and anti-inflammatories (Dexketoprofen-25mg/8h/3days) were prescribed, together with a clorhexidine 0.20 % gel twice a day for one week. Patients were then recalled for a post-operative check-up and sutures were removed after 14 days.
At 3 months, final impressions were made. After abutment selection and bisque try-ins, final restorations were permanently placed at 4 months.
The tooth-supported acrylic resin measuring stent was then adapted to allow for a complete fit on the incisal edges of both neighbouring teeth, to ensure a reliable positioning and measurement reference.
The first measurement was at day 0 (Immediate implant placement and provisionalisation). Patient recall appointments for examinations and measurements took place at 3, 6 and 12 months. No activities were performed to increase compliance or adherence in the selected patients beyong compliance of a good clinical practice.
Outcome measures The primary outcome variable of this study was the vertical midfacial soft tissue change from baseline (before tooth extraction) to 12 months following implant placement.
The secondary outcome measures were mesial and distal papillae vertical changes, periodontal phenotype at implant site, and mechanical complications.
The clinical outcomes were measured as follows:
- Vertical soft tissue changes were calculated through the distance from reference measuring points on the stent to mesial (MP) and distal (DP) papillae, and gingival zenith (Z) of the implant restoration. Distances were measured by means of a precision digital calliper that can display measurements as small as tenths of a millimetre. Three dimples were marked in the stent, in approximately the vertical projection of papillae and zenith (Supplementary figure 1a). Measurements were taken before tooth extraction (baseline) T0 and at 3 (T3), 6 (T6) and 12 (T12) months following the intervention.
- Periodontal phenotype thickness was measured by means of an analogical calliper that was able to show tenths of a millimetre. It was located 5 mm apical to the buccal gingival margin immediately after tooth extraction.
- Mechanical complications were assessed and included: screw loosening, loss of retention, chipping of acrylic or porcelain complications.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Trimodal Approach with Osseous and Mucosal compartment modification: TAOM | Experimental | Procedure: TAOMFlapless immediate implant placement and provisional restoration with alveolar filling and connective tissue graft. |
| Trimodal Approach: TA | Active comparator | Procedure: TAOMFlapless immediate implant placement and provisional restoration. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Need for tooth extraction in the anterior maxilla (13-23) due to cavities, internal resorption, fractures, restorative problems, endodontic complications and prosthetic reasons.
- The failing tooth has adjacent and opposing natural teeth
- Adequate oral hygiene (Bleeding on probing <20%; Plaque index <20%);
- Absence of active and uncontrolled periodontal disease
- Sufficient mesial-distal and interocclusal space for implant placement and definitive restoration
Key exclusion criteria (4 listed)
- Systemic metabolic or osseous disease that could compromise peri-implant tissue healing.
- Acute infection in the treatment area
- Absence of one or both adjacent teeth
- Non-integrity of the buccal bone wall (dehiscence or fenestration) observed during surgery, or when tooth extraction has altered the integrity of the osseous and gingival architecture
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TAOMAlso: Trimodal approach with osseous and mucosal interventions.In the TAOM group, the gap between the implant and the facial bone wall was grafted with inorganic bovine bone (Geistlich Bio-Oss®; Geistlich Pharma AG, Wolhusen, Switzerland) and, in addition, a connective tissue graft (CTG) was placed submucosally on the labial bone plate by means of an envelope technique. | Procedure or surgery | Trimodal Approach with Osseous and Mucosal compartment modification: TAOM, Trimodal Approach: TA |
Primary outcome
Distance from measuring points on the reference stent to gingival zenith of the implant restoration in tenths of a milimetre by means of a precision digital calliper.
Time frame: 12 months
Vertical midfacial soft tissue change from baseline (before tooth extraction) to 12 months following implant placement.
2 secondary outcomes
Distance from measuring points on the reference stent to mesial and distal papillae of the implant restoration in tenths of a milimetres by means of a precision digital calliper.
Time frame: 12 months
Periodontal thickness at 5mm apical to the gingival margin in tenths of a milimetre.
Time frame: Baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jul 2023.
Related trials for Dental Implant
Not yet recruiting
Free Soft Tissue Grafts (FSTG) Using Autograft Palatal Donor Tissue vs. Xenograft Collagen Matrix (Zderm™)
Gingival Recession Localized Moderate, Dental Implant
Not yet recruiting
Safety Assessment of Placing a Single Dental Implant Without Antibiotic Prophylaxis in Simple Cases: A Pilot Study
Tooth Loss and Rehabillitation, Dental Implant Failure
Active, not recruiting
L-PRF Block vs Composite Graft for Horizontal Ridge Augmentation
Alveolar Ridge Resorption After Extraction, Alveolar Bone Loss
RecruitingObservational study
Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants
Dental Implants
Active, not recruiting
The Aim of the Study Will be Clinically and Radio Graphically Comparison of Two Implant Designs Used to Treat Atrophied Mandible . Implant Design Comparison Will Done for Implant Stability,Peri-implant Soft Tissue Health Changes and Bone Changes .Patients Will be Divided Randomly Into Two Group
Dental Implant Bone Loss, Peri-Implant Health
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gustavo G Cabello principal investigator
Private Practice, Málaga, Spain
Javier J Fabrega principal investigator
Private Practice, Madrid, Spain
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing TAOM in people with Dental Implant, run by Universidad Complutense de Madrid at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Distance from measuring points on the reference stent to gingival zenith of the implant restoration in tenths of a milimetre by means of a precision digital calliper. (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2023.